ConductScience.org, home

Paper29659751

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.

Wilkin TJ and 13 others. Clin Infect Dis, 2018. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298. Papers, record 29659751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29659751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2018
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
5.21
iCite
Revised in PubMed
2024-03-14
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilkin TJTimothy J
2Chen HHuichao
3Cespedes MSMichelle S
4Leon-Cruz JTJorge T
5Godfrey CCatherine
6Chiao EYElizabeth Y
7Bastow BBarbara
8Webster-Cyriaque JJennifer
9Feng QQinghua
10Dragavon JJoan
11Coombs RWRobert W
12Presti RMRachel M
13Saah AAlfred
14Cranston RDRoss D

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
HIV InfectionsMajor topic
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Major topic
Oropharyngeal NeoplasmsMajor topic
Papillomavirus InfectionsMajor topic
Adult
Anal Canal
Brazil
Double-Blind Method
Early Termination of Clinical Trials
Female
Humans
Male
Medical Futility
Middle Aged
Mouth
Papillomaviridae
Vaccine Potency

Source PubMed

Download CSV of topics

Grants38

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UM1 AI069472NIAID NIH HHSUnited StatesU01AI069472PubMed and NIHNIH RePORTER
UM1 AI069470NIAID NIH HHSUnited StatesUM1AI069470PubMed and NIHNIH RePORTER
UM1 AI069471NIAID NIH HHSUnited StatesU01AI069471PubMed and NIHNIH RePORTER
UL1 TR000457NCATS NIH HHSUnited StatesUL1TR000457PubMed and NIHNIH RePORTER
U01 AI069471NIAID NIH HHSUnited StatesU01AI069471PubMed and NIHNIH RePORTER
UM1 AI069496NIAID NIH HHSUnited StatesUM1AI069496PubMed and NIHNIH RePORTER
UM1 AI069439NIAID NIH HHSUnited StatesUM1AI069439PubMed and NIHNIH RePORTER
U01 AI069503NIAID NIH HHSUnited StatesU01AI069503PubMed and NIHNIH RePORTER
UM1 AI069412NIAID NIH HHSUnited StatesUM1AI069412PubMed and NIHNIH RePORTER
UM1 AI106701NIAID NIH HHSUnited StatesUM1AI106701PubMed and NIHNIH RePORTER
UM1 AI069424NIAID NIH HHSUnited StatesUM1AI069424PubMed and NIHNIH RePORTER
U01 AI069419NIAID NIH HHSUnited StatesU01AI069419PubMed and NIHNIH RePORTER
UM1 AI069494NIAID NIH HHSUnited StatesUM1AI069494PubMed and NIHNIH RePORTER
UM1 AI069503NIAID NIH HHSUnited StatesU01AI069503PubMed and NIHNIH RePORTER
UL1 TR000042NCATS NIH HHSUnited StatesUL1TR000042PubMed and NIHNIH RePORTER
UL1 TR001111NCATS NIH HHSUnited StatesUL1TR001111PubMed and NIHNIH RePORTER
UM1 AI069432NIAID NIH HHSUnited StatesUM1AI069432PubMed and NIHNIH RePORTER
P30 CA016086NCI NIH HHSUnited StatesP30CA016086PubMed and NIHNIH RePORTER
UL1 TR001082NCATS NIH HHSUnited StatesUL1TR001082PubMed and NIHNIH RePORTER
UM1 AI069556NIAID NIH HHSUnited StatesUM1AI069556PubMed and NIHNIH RePORTER

See all 38 grantsDownload CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01461096Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and WomenDerived from the trialYesClinicalTrials.gov
NCT04270773Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive WomenBackgroundClinicalTrials.gov

Download CSV of trials

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125925419US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.J Natl Cancer Inst2015https://conductscience.org/library/papers/25925419PubMed
215849533Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy.Sex Transm Dis2005https://conductscience.org/library/papers/15849533PubMed
322291111Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.Clin Infect Dis2012https://conductscience.org/library/papers/22291111PubMed
422454089Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.BMJ2012https://conductscience.org/library/papers/22454089PubMed
516272481Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.J Clin Microbiol2005https://conductscience.org/library/papers/16272481PubMed
619239366Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study.J Infect Dis2009https://conductscience.org/library/papers/19239366PubMed
720812850Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.J Infect Dis2010https://conductscience.org/library/papers/20812850PubMed
820610686Evaluation of transported dry and wet cervical exfoliated samples for detection of human papillomavirus infection.J Clin Microbiol2010https://conductscience.org/library/papers/20610686PubMed
924751181Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.Emerg Infect Dis2014https://conductscience.org/library/papers/24751181PubMed
1015577408HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?J Acquir Immune Defic Syndr2004https://conductscience.org/library/papers/15577408PubMed
1129049523Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014.Ann Intern Med2017https://conductscience.org/library/papers/29049523PubMed
1224723284Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.Clin Infect Dis2014https://conductscience.org/library/papers/24723284PubMed
1327387669Human Papillomavirus-Associated Cancers - United States, 2008-2012.MMWR Morb Mortal Wkly Rep2016https://conductscience.org/library/papers/27387669PubMed
1424235263Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.Clin Infect Dis2014https://conductscience.org/library/papers/24235263PubMed
1519144800Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses.J Clin Microbiol2009https://conductscience.org/library/papers/19144800PubMed
1611151066Use of buccal cells collected in mouthwash as a source of DNA for clinical testing.Arch Pathol Lab Med2001https://conductscience.org/library/papers/11151066PubMed
1725976897Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.Int J Cancer2015https://conductscience.org/library/papers/25976897PubMed
1818614927Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study.J Acquir Immune Defic Syndr2008https://conductscience.org/library/papers/18614927PubMed
1922445259Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.Lancet Oncol2012https://conductscience.org/library/papers/22445259PubMed
208841649A non-parametric test for interval-censored failure time data with application to AIDS studies.Stat Med1996https://conductscience.org/library/papers/8841649PubMed

See all 35 referencesDownload CSV of references

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
42807817HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design.Front Immunol2026https://conductscience.org/library/papers/42807817PubMed
42775839Sexually transmitted infection syndemic interactions: Biological amplification between HIV, HSV-2, syphilis, and HPV and implications for co-treatment strategies.Sci Prog2026https://conductscience.org/library/papers/42775839PubMed
42726205[Vaccine prevention of HPV-associated diseases].Dermatologie (Heidelb)2026https://conductscience.org/library/papers/42726205PubMed
42684271Immunogenicity and safety of prophylactic HPV vaccines in people living with HIV: A systematic review and meta-analysis.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42684271PubMed
42649891Anal High-Grade Squamous Intraepithelial Lesions in People Living with HIV: A Systematic Review of Treatment Outcomes.Cancers (Basel)2026https://conductscience.org/library/papers/42649891PubMed
42583010Incidence and burden of anal cancer-time to fight the growing disparities.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42583010PubMed
42453776Evaluation of Anal Cancer Screening Among 18-to-34-Year-Old Men Who Have Sex With Men Living With HIV Over a 10-Year Period.Open Forum Infect Dis2026https://conductscience.org/library/papers/42453776PubMed
42070588Genotype distribution of human papillomavirus (HPV) types in oral gargle specimens among men living with HIV in Mexico, Brazil, and Puerto Rico: A cross-sectional study.J Infect2026https://conductscience.org/library/papers/42070588PubMed
41866610Closing the Gap: HPV Vaccination and Head and Neck Cancer Prevention.Curr Oncol Rep2026https://conductscience.org/library/papers/41866610PubMed
41746114Advances in HPV Vaccination in People Living with HIV: A Review.Vaccines (Basel)2026https://conductscience.org/library/papers/41746114PubMed
41725297Long-term intraanal HPV16 infection in men having sex with men with HIV: Persistence or reinfection?J Eur Acad Dermatol Venereol2026https://conductscience.org/library/papers/41725297PubMed
41685810Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial.Int J Cancer2026https://conductscience.org/library/papers/41685810PubMed
41586588Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study.Hum Vaccin Immunother2026https://conductscience.org/library/papers/41586588PubMed
41188885Ageing with HIV-1: immunological challenges for effective vaccination.Immun Ageing2025https://conductscience.org/library/papers/41188885PubMed
41177815Anal Squamous Intraepithelial Lesions: A Primer for Gastroenterologists.Curr Gastroenterol Rep2025https://conductscience.org/library/papers/41177815PubMed
40794702A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017.Clin Infect Dis2026https://conductscience.org/library/papers/40794702PubMed
40609265
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201.
Vaccine2025https://conductscience.org/library/papers/40609265PubMed
40338823Vaccine effectiveness against anal HPV infection among men with HIV who have sex with men attending sexual health clinics in three United States cities, 2018-2023.J Acquir Immune Defic Syndr2025https://conductscience.org/library/papers/40338823PubMed
40334187The epidemiology and risk factors of anal and oropharyngeal human papillomavirus (HPV) in males living with human immunodeficiency virus (HIV): A protocol for systematic review and meta-analysis.PLoS One2025https://conductscience.org/library/papers/40334187PubMed
39976870Update on Vaccination Recommendations for Adults with HIV.Curr HIV/AIDS Rep2025https://conductscience.org/library/papers/39976870PubMed

See all 81 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29659751

GET https://conductscience.org/api/papers/v1/29659751/grants?page=2